|
2.
|
|
6 p, 377.9 KB |
Clinical and genetic differences between pustular psoriasis subtypes
/
Twelves, Sophie (King's College London) ;
Mostafa, Alshimaa (Beni Suef University) ;
Dand, Nick (King's College London) ;
Burri, Elias (University Hospital Zurich (Suïssa)) ;
Farkas, K. (University of Szeged) ;
Wilson, Rosemary (King's College London) ;
Cooper, Hywel L. (Portsmouth Hospitals Trust) ;
Irvine, Alan D. (Trinity College Dublin) ;
Oon, Hazel H. (National Skin Centre) ;
Kingo, Külli (Tartu University Hospital (Tartu, Estònia)) ;
Köks, Sulev (University of Tartu) ;
Mrowietz, Ulrich (University Medical Center Schleswig-Holstein) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Reynolds, Nick (Newcastle Hospitals NHS Foundation Trust) ;
Tan, Euegene Sern-Ting (National Skin Centre) ;
Tanew, Adrian (Medical University of Vienna) ;
Torz, Kaspar (Campus Kiel) ;
Trattner, Hannes (Medical University of Vienna) ;
Valentine, Mark (University of Washington School of Medicine) ;
Wahie, Shyamal (University Hospital of North Durham and Darlington Memorial Hospital) ;
Warren, Richard B. (University of Manchester and the Academic Health Science Centre) ;
Wright, Andrew (St University of Bradford) ;
Bata-Csörgő, Zsuzsa (University of Szeged) ;
Szell, Marta (University of Szeged) ;
Griffiths, Christopher E.M. (University of Manchester and the Academic Health Science Centre) ;
Burden, A.David (University of Glasgow) ;
Choon, Siew-Eng (Monash University Malaysia) ;
Smith, Catherine H. (King's College London) ;
Barker, Jonathan N. (King's College London) ;
Navarini, Alexander A. (University Hospital Zurich (Suïssa)) ;
Capon, Francesca (King's College London) ;
Universitat Autònoma de Barcelona
The term pustular psoriasis indicates a group of severe skin disorders characterized by eruptions of neutrophil-filled pustules. The disease, which often manifests with concurrent psoriasis vulgaris, can have an acute systemic (generalized pustular psoriasis [GPP]) or chronic localized (palmoplantar pustulosis [PPP] and acrodermatitis continua of Hallopeau [ACH]) presentation. [...]
2019 -  10.1016/j.jaci.2018.06.038
The Journal of Allergy and Clinical Immunology, Vol. 143 Núm. 3 (march 2019) , p. 1021-1026
|
|
|
3.
|
|
21 p, 278.8 KB |
Long-term prognosis for 1-year relapse-free survivors of CD34 cell-selected allogeneic hematopoietic stem cell transplantation : a landmark analysis
/
Cho, Christina (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Hsu, Meier (Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Maloy, Molly A. (Memorial Sloan Kettering Cancer Center) ;
Avecilla, Scott T. (Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Barker, Juliet N. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Castro-Malaspina, Hugo (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Giralt, Sergio A. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Jakubowski, Ann A. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Koehne, Guenther (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Meagher, Richard C. (Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
O'Reilly, Richard J. (Memorial Sloan Kettering Cancer Center) ;
Papadopoulos, Esperanza B. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Ponce, Doris M. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Tamari, Roni (Weill Cornell Medical College, New York, NY, 10065, USA) ;
van den Brink, Marcel R. M. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Young, James W. (The Rockefeller University, New York, NY, 10065, USA) ;
Devlin, Sean M. (Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Perales, Miguel-Angel (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Universitat Autònoma de Barcelona
CD34 selection significantly improves GVHD-free survival in allogeneic hematopoietic cell transplantation (allo-HSCT). Specific information regarding long-term prognosis and risk factors for late mortality after CD34-selected allo-HSCT is lacking, however. [...]
2017 - 10.1038/bmt.2017.197
Bone marrow transplantation, Vol. 52 (october 2017) , p. 1629-1636
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
